![Georg Börtlein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Georg Börtlein is the founder.
He founded HighLife SAS in 2010 and currently holds the title of Managing Director & Director.
In addition to his founding position, Mr. Börtlein also worked as the Chief Operating Officer at CoreValve SA.
Aktive Positionen von Georg Börtlein
Unternehmen | Position | Beginn |
---|---|---|
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Gründer | 01.01.2010 |
Ehemalige bekannte Positionen von Georg Börtlein
Unternehmen | Position | Ende |
---|---|---|
CoreValve SA
![]() CoreValve SA Medical SpecialtiesHealth Technology CoreValve SA develops implants and instruments for heart surgery. It offers aortic bioprostheses, delivery catheters, disposable loading systems and other related products. The company was founded by Jacques Seguin in 2001 and is headquartered in Paris, France. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CoreValve SA
![]() CoreValve SA Medical SpecialtiesHealth Technology CoreValve SA develops implants and instruments for heart surgery. It offers aortic bioprostheses, delivery catheters, disposable loading systems and other related products. The company was founded by Jacques Seguin in 2001 and is headquartered in Paris, France. | Health Technology |
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Health Technology |